Publicaciones en colaboración con investigadores/as de Universidade de Santiago de Compostela (18)

2017

  1. Structure-Performance Relationships of Temperature-Responsive PLGA-PEG-PLGA Gels for Sustained Release of Bone Morphogenetic Protein-2

    Journal of Pharmaceutical Sciences, Vol. 106, Núm. 11, pp. 3353-3362

2009

  1. hGH release from directly compressed hGH-PLGA biodegradable implantable tablets: Influence of physicomechanical factors

    European Polymer Journal, Vol. 45, Núm. 10, pp. 2830-2838

2005

  1. Structural properties of biodegradable polyesters and rheological behaviour of their dispersions and films

    Journal of Biomaterials Science, Polymer Edition, Vol. 16, Núm. 5, pp. 629-641

2004

  1. Rheological properties of PLGA film-based implants: Correlation with polymer degradation and SPf66 antimalaric synthetic peptide release

    Biomaterials, Vol. 25, Núm. 5, pp. 925-931

1987

  1. Dissolution rate and bioavailability of spironolactone tablets: Effect of various technological factors

    Drug Development and Industrial Pharmacy, Vol. 13, Núm. 12, pp. 2301-2314

1986

  1. EFECTO DEL pH Y FLUJO URINARIO SOBRE LA EVALUACION DE LA BIODISPONIBILIDAD ORAL DE LA SULFADIAZINA

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 10, pp. 309-315

  2. ESTIMACION DE LA VELOCIDAD INTRINSECA DE DISOLUCION EN SISTEMAS DE DISOLUCION SIN RECIRCULACION DE FLUIDO Y SIN RESERVORIO DE ACUMULACION

    Ciencia e Industria Farmaceutica, Vol. 5, Núm. 6, pp. 189-192

  3. Limitations of the MANOVA of statistical moments in bioequivalence trials of drugs with slow elimination rate: A study with spironolactone

    Biopharmaceutics & Drug Disposition, Vol. 7, Núm. 3, pp. 253-264

  4. Technological factors and bioavailability of spironolactone tablets. II. In vivo results

    Sciences Techniques et Pratiques Pharmaceutiques, Vol. 2, Núm. 12, pp. 28-33

1985

  1. Technological factors and bioavailability of spironolactone tablets. I. In vitro results

    Sciences Techniques et Pratiques Pharmaceutiques, Vol. 1, Núm. 11, pp. 1053-1056

1984

  1. EFECTO DE LA FUERZA DE COMPRESION Y NIVEL DE AGLUTINANTE SOBRE LAS CARACTERISTICAS GALENICAS DE COMPRIMIDOS DE SULFADIAZINA

    Ciencia e Industria Farmaceutica, Vol. 3, Núm. 2, pp. 46-49

1982

  1. BIODISPONIBILIDAD ORAL DE CEFADROXIL: INFLUENCIA DE LOS ALIMENTOS

    Archivos de Farmacologia y Toxicologia, Vol. 8, Núm. 3, pp. 171-178

  2. METODO DENSITOMETRICO PARA LA DETERMINACION DE PARACETAMOL EN LA ORINA

    Ciencia e Industria Farmaceutica, Vol. 1, Núm. 2, pp. 38-41

  3. Quantification of the effect of excipients on bioavailability by means of response surfaces I: Amoxicillin in fat matrix

    Journal of Pharmaceutical Sciences, Vol. 71, Núm. 8, pp. 924-927

  4. Quantification of the effect of excipients on bioavailability by means of response surfaces II: Amoxicillin in fat‐silica matrix

    Journal of Pharmaceutical Sciences, Vol. 71, Núm. 8, pp. 927-930

  5. Quantification of the effect of excipients on bioavailability by means of response surfaces III: In vivo‐in vitro correlations

    Journal of Pharmaceutical Sciences, Vol. 71, Núm. 8, pp. 930-932

1980

  1. MANOVA of statistical moments in biopharmaceutical studies: A numerical example with three equally spaced doses of amoxicillin

    Journal of Pharmacokinetics and Biopharmaceutics, Vol. 8, Núm. 4, pp. 411-420

1978

  1. Calculo de la velocidad de disolucion en sistemas sin recirculacion de fluido y sin reservorio de acumulacion

    Farmaco, Edizione Pratica, Vol. 33, Núm. 3, pp. 111-118